Organogenesis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Organogenesis and other ETFs, options, and stocks.About ORGO
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
CEOGary S. Gillheeney
CEOGary S. Gillheeney
Employees869
Employees869
HeadquartersCanton, Massachusetts
HeadquartersCanton, Massachusetts
Founded1985
Founded1985
Employees869
Employees869
ORGO Key Statistics
Market cap618.17M
Market cap618.17M
Price-Earnings ratio-49.13
Price-Earnings ratio-49.13
Dividend yield—
Dividend yield—
Average volume1.47M
Average volume1.47M
High today$4.84
High today$4.84
Low today$4.66
Low today$4.66
Open price$4.75
Open price$4.75
Volume3.60M
Volume3.60M
52 Week high$7.08
52 Week high$7.08
52 Week low$2.61
52 Week low$2.61
Stock Snapshot
The current Organogenesis(ORGO) stock price is $4.83, with a market capitalization of 618.17M. The stock trades at a price-to-earnings (P/E) ratio of -49.13.
On 2025-12-13, Organogenesis(ORGO) stock traded between a low of $4.66 and a high of $4.84. Shares are currently priced at $4.83, which is +3.6% above the low and -0.2% below the high.
The Organogenesis(ORGO)'s current trading volume is 3.6M, compared to an average daily volume of 1.47M.
In the last year, Organogenesis(ORGO) shares hit a 52-week high of $7.08 and a 52-week low of $2.61.
In the last year, Organogenesis(ORGO) shares hit a 52-week high of $7.08 and a 52-week low of $2.61.
People also own
Based on the portfolios of people who own ORGO. This list is generated using Robinhood data, and it’s not a recommendation.